Outrun Therapeutics

Outrun Therapeutics has developed a proprietary platform technology for the identification of therapeutics that selectively target the protein modulation pathway

Team Members
more about
Cheryl Zimberlin
Investment Director
more about
Bauke Anninga
Principal
all portfolio news